计算溶液所需的质量、体积或浓度。
提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,避光,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 ( VMAT2 ).
In Vitro
Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 (VMAT2). Reserpine hydrochloride displays a significant on the density of dopamine D1 receptors (F 2,12 =8.81, p<0.01) in the rat striatum. The affinity (Kd) for the dopamine D1 and D2 receptors during withdrawal from acute and chronic administration of reserpine is not change. IC 50 values of 43.9 and 54.9 μM are obtained after 1 day of treatment with Reserpine hydrochloride in JB6 P+ and HepG2-C8 cells, respectively. Reserpine hydrochloride induces luciferase activity in a dose-dependent manner at concentrations ranging from 5 to 50 μM, and no significant induction is observed at concentrations lower than 5 μM. Results demonstrate that Reserpine hydrochloride (2.5 to 10 μM) also increases the protein expression of Nrf2, HO-1, and NQO1. Reserpine hydrochloride at concentrations of 2.5 to 10 μM decreases the mRNA expression of DNMT1, DNMT3a, and DNMT3b in a concentration-dependent manner in JB6 P+ cells after 7 days of treatment. Reserpine hydrochloride at 10 μM generates a significant difference for DNMT3a expression (p<0.05). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Withdrawal (48 h) from chronic (14-day) but not acute Reserpine hydrochloride administration in a dose of 0.2 mg/kg i.p. produces a significant reduction of the immobility time (F 2,18 =3.68, p<0.05), but increases the climbing time (F 2,18 =4.48, p<0.02), and does not change the swimming time (F 2,18 =1.78; NS) in the forced swim test (FST) in rats . Reserpine hydrochloride at a dose of 5 mg/kg body weight produces significant increase in the urinary excretion profile of vanillylmandelic acid (VMA) compare to control animals. The amount of 5-hydroxyindoleacetic acid (5-HIAA) excreted in animals treated with Reserpine is found to be more than in the control. Dose dependent hypotension is observed with Reserpine hydrochloride. Reserpine hydrochloride at doses of 0.5, 1, 5, 10 and 15 μg/kg produce significant (p<0.01) reduction in blood pressure compare to control. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Assay
JB6 P+ cells are seeded in 96-well plates containing Minimum essential media (MEM) at a density of 1×10 4 cells/mL ( 100 μL/well ) for 1, 3, and 5 days, and HepG2-C8 cells are seeded in plates containing DMEM. After incubation for 24 h, the cells are treated with either DMSO or various concentrations of Reserpine hydrochloride . For JB6 P+ cells, the medium is changed every 2 days for the 3-day and 5-day treatments. Cell viability is assessed using a MTS assay kit according to the manufacturer’s instructions. The absorbance of the formazan product is read at 490 nm, and the cell viability is calculated and compared with the DMSO control group. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
IC50& Target:VMAT2
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 生物碱及其衍生物 |
| 类(Class) | 育亨宾生物碱 |
| 亚类(Subclass) | 暂无 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 育亨宾生物碱 |
| 其他上位类(Alternative Parents) | 柯南斯型生物碱 β-咔啉 没食子酸及其衍生物 对甲氧基苯甲酸及其衍生物 间甲氧基苯甲酸及其衍生物 3-烷基吲哚 苯甲酸酯 苯氧基化合物 茴香醚 苯甲酰衍生物 甲氧基苯 烷基芳基醚 芳烷基胺 哌啶类 吡咯类 甲酯 杂芳族化合物 三烷基胺 氨基酸及其衍生物 一元羧酸及其衍生物 氮杂环化合物 二烷基醚 羰基化合物 盐酸盐 有机氧化物 有机光子化合物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 3-烷基吲哚 - 芳基醚 - 氨基酸 - 氨基酸或其衍生物 - 茴香醚 - 芳烷基胺 - 芳香族杂多环化合物 - 氮杂环 - 苯基化合物 - 苯甲酸酯 - 苯甲酸或衍生物 - 苯甲酰 - β-羟基苯甲醛 - 羰基 - 羧酸衍生物 - 羧酸酰胺 - 蒽醌骨架 - 二烷基醚 - 乙醚 - 没食子酸或其衍生物 - 杂芳香族化合物 - 烃衍生物 - 氟氯烃 - 吲哚 - 吲哚或其衍生物 - 邻甲氧基苯甲酸或其衍生物 - 甲氧基苯 - 甲酯 - 单羧酸或其衍生物 - 单环苯基基团 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 对甲氧基苯甲酸或其衍生物 - 苯酚醚 - 苯氧基化合物 - 哌嗪 - 吡啶吲哚 - 吡咯 - 三元脂肪胺 - 三芳基胺 - Yohimbine - Yohimbine alkaloid |
| 描述(Description) | 该化合物属于称为育亨宾生物碱的有机化合物类别。这类生物碱含有五环育亨宾骨架。育亨宾类生物碱通过在柯兰坦碱前体中形成C-17至C-18键而具有碳环结构E。 |
| 外部描述符(External Descriptors) | 暂无 |